TLR2/TLR4 antagonists or agonists may offer therapeutic benefits in eliciting an appropriate immune response during leishmaniasis, including L. braziliensis; Additionally, TLR agonists can serve as adjuvants in anti-leishmania vaccines58. This evidence concerns the gene TLR4 and leishmaniasis.